CDC says COVID vaccine protects pregnant women
Michael Hiltzik,
Tribune News Service
Here's how one of the well-laid plans of Health and Human Services Secretary Robert F. Kennedy Jr. went blooey. Earlier this month, Kennedy dismantled the all-important Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, and remade it into the spearhead for his anti-vaccination campaigns. The rejiggered committee met for the first time Wednesday. Unfortunately for Kennedy's goals, the very first presentation it heard from CDC scientists involved the safety of the COVID-19 vaccine, particularly for pregnant women, infants and children. CDC studies found "no increased risk" that the Moderna and Pfizer mRNA vaccines caused adverse effects during pregnancy, Sarah Meyer, director of the CDC's Immunization Safety Office, said at the meeting, citing data from 28 analyses of 68,000 pregnant women. The data showed no increases in miscarriages, stillbirths, preterm births, major birth defects, neonatal ICU admissions, infant deaths, abnormal uterine bleeding or other pregnancy-related conditions.
In fact, the CDC found that "maternal vaccination is the best proection against COVID-19 for pregnant women and infants less than six months of age," CDC immunologist Adam MacNeil told the panel. The COVID vaccines aren't approved for infants younger than six months, so maternal immunization is their only protection. That's important because Kennedy, on May 17, removed the vaccines from the recommended list for pregnant women and children. "It's common sense and it's good science" to remove the recommendation, Kennedy said in a 58-second video posted on X. "We're now one step closer to realising President Trump's promise to make America healthy again," Kennedy crowed, flanked by Marty Makary, the newly appointed commissioner of the Food and Drug Administration, and Jay Bhattacharya, the newly appointed director of the National Institutes of Health.
Neither body plays a role in issuing vaccine recommendations for the government. That's the job of the CDC, which has been operating without a director, and which didn't have a representative on the video. Pediatric and obstetric organisations decried the decision, which ran counter to the findings of extensive research. "Clear benefits of maternal immunisation versus COVID in terms of dramatic reductions in maternal mortality and protecting the newborn infant ... has been detailed in the biomedical literature," vaccinologist Peter Hotez told me by email. I asked Kennedy through his agency's public information team for comment on the CDC presentation, but received no reply. On June 9, Kennedy fired all 17 members of ACIP of the immunization advisory committee and replaced them with eight handpicked members, a cadre that includes "antivaxxers, the antivax-adjacent, and the unqualified," as veteran pseudoscience debunker David Gorski noted. The COVID vaccines have been a leading target of anti-vaccine activists, including Kennedy, since they were introduced in 2021. They've been blamed for a host of purported health harms, most of which have been found by researchers to be largely imaginary.
The anti-vaccine camp maintains that the vaccines weren't adequately studied before rolling them out to the general public and haven't been sufficiently monitored for adverse effects since then. The CDC officials' presentation debunked almost all these claims. Indeed, Meyer said, the COVID-19 vaccines have been subjected to "the most extensive safety monitoring programe in US history." The CDC has investigated more than 65 possible adverse effects of the vaccine, Meyer said, including heart attacks, meningitis, spontaneous abortion, seizures and hospitalisation. Other than pain at the injection site, fainting and other transitory conditions common to most vaccines, it has found evidence for one condition — myocarditis, a heart inflammation seen especially in men aged 12 to 29.
That appears to be a short-term condition, with 83% of patients recovering within 90 days of onset, and more than 90% fully recovered within a year. No deaths or heart transplants are known to have occurred, the CDC data show. No confirmed cases were seen in children younger than 5. The myocarditis rate among vaccine recipients aged between 6 months and 64 years appeared to spike in 2020-22, when it seemed to be related to the original vaccine and the original booster. After the booster was reformulated, the rate among those aged 12 to 39 fell to about one case per million doses in 2024-25 — half the rate found in the general population. Despite the relative rarity of myocarditis, the condition has underpinned a campaign by anti-vaccine activists to take the vaccines off the market. Among them is Joseph Ladapo, the Florida surgeon general, who in 2022 advised males aged 18-39 not to get the COVID vaccine.
His advisory earned him a crisp upbraiding from the then-heads of the FDA and CDC, who informed him by letter that "the known and potential benefits of these vaccines clearly outweigh their known and potential risks.... Not only is there no evidence of increased risk of death following mRNA vaccines, but available data have shown quite the opposite: that being up to date on vaccinations saves lives compared to individuals who did not get vaccinated."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Today
17 hours ago
- Gulf Today
CDC says COVID vaccine protects pregnant women
Michael Hiltzik, Tribune News Service Here's how one of the well-laid plans of Health and Human Services Secretary Robert F. Kennedy Jr. went blooey. Earlier this month, Kennedy dismantled the all-important Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, and remade it into the spearhead for his anti-vaccination campaigns. The rejiggered committee met for the first time Wednesday. Unfortunately for Kennedy's goals, the very first presentation it heard from CDC scientists involved the safety of the COVID-19 vaccine, particularly for pregnant women, infants and children. CDC studies found "no increased risk" that the Moderna and Pfizer mRNA vaccines caused adverse effects during pregnancy, Sarah Meyer, director of the CDC's Immunization Safety Office, said at the meeting, citing data from 28 analyses of 68,000 pregnant women. The data showed no increases in miscarriages, stillbirths, preterm births, major birth defects, neonatal ICU admissions, infant deaths, abnormal uterine bleeding or other pregnancy-related conditions. In fact, the CDC found that "maternal vaccination is the best proection against COVID-19 for pregnant women and infants less than six months of age," CDC immunologist Adam MacNeil told the panel. The COVID vaccines aren't approved for infants younger than six months, so maternal immunization is their only protection. That's important because Kennedy, on May 17, removed the vaccines from the recommended list for pregnant women and children. "It's common sense and it's good science" to remove the recommendation, Kennedy said in a 58-second video posted on X. "We're now one step closer to realising President Trump's promise to make America healthy again," Kennedy crowed, flanked by Marty Makary, the newly appointed commissioner of the Food and Drug Administration, and Jay Bhattacharya, the newly appointed director of the National Institutes of Health. Neither body plays a role in issuing vaccine recommendations for the government. That's the job of the CDC, which has been operating without a director, and which didn't have a representative on the video. Pediatric and obstetric organisations decried the decision, which ran counter to the findings of extensive research. "Clear benefits of maternal immunisation versus COVID in terms of dramatic reductions in maternal mortality and protecting the newborn infant ... has been detailed in the biomedical literature," vaccinologist Peter Hotez told me by email. I asked Kennedy through his agency's public information team for comment on the CDC presentation, but received no reply. On June 9, Kennedy fired all 17 members of ACIP of the immunization advisory committee and replaced them with eight handpicked members, a cadre that includes "antivaxxers, the antivax-adjacent, and the unqualified," as veteran pseudoscience debunker David Gorski noted. The COVID vaccines have been a leading target of anti-vaccine activists, including Kennedy, since they were introduced in 2021. They've been blamed for a host of purported health harms, most of which have been found by researchers to be largely imaginary. The anti-vaccine camp maintains that the vaccines weren't adequately studied before rolling them out to the general public and haven't been sufficiently monitored for adverse effects since then. The CDC officials' presentation debunked almost all these claims. Indeed, Meyer said, the COVID-19 vaccines have been subjected to "the most extensive safety monitoring programe in US history." The CDC has investigated more than 65 possible adverse effects of the vaccine, Meyer said, including heart attacks, meningitis, spontaneous abortion, seizures and hospitalisation. Other than pain at the injection site, fainting and other transitory conditions common to most vaccines, it has found evidence for one condition — myocarditis, a heart inflammation seen especially in men aged 12 to 29. That appears to be a short-term condition, with 83% of patients recovering within 90 days of onset, and more than 90% fully recovered within a year. No deaths or heart transplants are known to have occurred, the CDC data show. No confirmed cases were seen in children younger than 5. The myocarditis rate among vaccine recipients aged between 6 months and 64 years appeared to spike in 2020-22, when it seemed to be related to the original vaccine and the original booster. After the booster was reformulated, the rate among those aged 12 to 39 fell to about one case per million doses in 2024-25 — half the rate found in the general population. Despite the relative rarity of myocarditis, the condition has underpinned a campaign by anti-vaccine activists to take the vaccines off the market. Among them is Joseph Ladapo, the Florida surgeon general, who in 2022 advised males aged 18-39 not to get the COVID vaccine. His advisory earned him a crisp upbraiding from the then-heads of the FDA and CDC, who informed him by letter that "the known and potential benefits of these vaccines clearly outweigh their known and potential risks.... Not only is there no evidence of increased risk of death following mRNA vaccines, but available data have shown quite the opposite: that being up to date on vaccinations saves lives compared to individuals who did not get vaccinated."
Gulf Today
3 days ago
- Gulf Today
Many older people are really eager to be vaccinated
Paula Span, Tribune News Service Kim Beckham, an insurance agent in Victoria, Texas, had seen friends suffer so badly from shingles that she wanted to receive the first approved shingles vaccine as soon as it became available, even if she had to pay for it out-of-pocket. Her doctor and several pharmacies turned her down because she was below the recommended age at the time, which was 60. So, in 2016, she celebrated her 60th birthday at her local CVS. 'I was there when they opened,' Beckham recalled. After getting her Zostavax shot, she said, 'I felt really relieved.' She has since received the newer, more effective shingles vaccine, as well as a pneumonia shot, an RSV vaccine to guard against respiratory syncytial virus, annual flu shots and all recommended COVID-19 vaccinations. Some older people are really eager to be vaccinated. Robin Wolaner, 71, a retired publisher in Sausalito, California, has been known to badger friends who delay getting recommended shots, sending them relevant medical studies. 'I'm sort of hectoring,' she acknowledged. Deana Hendrickson, 66, who provides daily care for three young grandsons in Los Angeles, sought an additional MMR shot, though she was vaccinated against measles, mumps, and rubella as a child, in case her immunity to measles had waned. For older adults who express more confidence in vaccine safety than younger groups, the past few months have brought welcome research. Studies have found important benefits from a newer vaccine and enhanced versions of older ones, and one vaccine may confer a major bonus that nobody foresaw. The new studies are coming at a fraught political moment. The nation's health secretary, Robert F. Kennedy Jr., has long disparaged certain vaccines, calling them unsafe and saying that the government officials who regulate them are compromised and corrupt. On June 9, Kennedy fired a panel of scientific advisers to the Centers for Disease Control and Prevention, and later replaced them with some who have been skeptical of vaccines. But so far, Kennedy has not tried to curb access to the shots for older Americans. The evidence that vaccines are beneficial remains overwhelming. The phrase 'Vaccines are not just for kids anymore' has become a favorite for William Schaffner, an infectious diseases specialist at Vanderbilt University Medical Center. 'The population over 65, which often suffers the worst impact of respiratory viruses and others, now has the benefit of vaccines that can prevent much of that serious illness,' he said. Take influenza, which annually sends from 140,000 to 710,000 people to hospitals, most of them seniors, and is fatal to 10% of hospitalized older adults. For about 15 years, the CDC has approved several enhanced flu vaccines for people 65 and older. More effective than the standard formulation, they either contain higher levels of the antigen that builds protection against the virus or incorporate an adjuvant that creates a stronger immune response. Or they're recombinant vaccines, developed through a different method, with higher antigen levels. In a meta-analysis in the Journal of the American Geriatrics Society, 'all the enhanced vaccine products were superior to the standard dose for preventing hospitalisations,' said Rebecca Morgan, a health research methodologist at Case Western Reserve University and an author of the study. Compared with the standard flu shot, the enhanced vaccines reduced the risk of hospitalization from the flu in older adults, by at least 11% and up to 18%. The CDC advises adults 65 and older to receive the enhanced vaccines, as many already do. More good news: Vaccines to prevent respiratory syncytial virus in people 60 and older are performing admirably. RSV is the most common cause of hospitalization for infants, and it also poses significant risks to older people. 'Season in and season out,' Schaffner said, 'it produces outbreaks of serious respiratory illness that rivals influenza.' Because the FDA first approved an RSV vaccine in 2023, the 2023-24 season provided 'the first opportunity to see it in a real-world context,' said Pauline Terebuh, an epidemiologist at Case Western Reserve School of Medicine and an author of a recent study in the journal JAMA Network Open. In analysing electronic health records for almost 800,000 patients, the researchers found the vaccines to be 75% effective against acute infection, meaning illness that was serious enough to send a patient to a health care provider. The vaccines were 75% effective in preventing emergency room or urgent care visits, and 75% effective against hospitalisation, both among those ages 60 to 74 and those older. Immunocompromised patients, despite having a somewhat lower level of protection from the vaccine, will also benefit from it, Terebuh said. As for adverse effects, the study found a very low risk for Guillain-Barré syndrome, a rare condition that causes muscle weakness and that typically follows an infection, in about 11 cases per 1 million doses of vaccine. That, she said, 'shouldn't dissuade people.' The CDC now recommends RSV vaccination for people 75 and older, and for those 60 to 74 if they're at higher risk of severe illness (from, say, heart disease). As data from the 2024-25 season becomes available, researchers hope to determine whether the vaccine will remain a one-and-done, or whether immunity will require repeated vaccination. People 65 and up express the greatest confidence in vaccine safety of any adult group, a KFF survey found in April. More than 80% said they were 'very 'or 'somewhat confident' about MMR, shingles, pneumonia, and flu shots. Although the COVID vaccine drew lower support among all adults, more than two-thirds of older adults expressed confidence in its safety. Even skeptics might become excited about one possible benefit of the shingles vaccine: This spring, Stanford researchers reported that over seven years, vaccination against shingles reduced the risk of dementia by 20%, a finding that made headlines. Biases often undermine observational studies that compare vaccinated with unvaccinated groups. 'People who are healthier and more health-motivated are the ones who get vaccinated,' said Pascal Geldsetzer, an epidemiologist at the Knight Initiative for Brain Resilience at Stanford and lead author of the study. 'It's hard to know whether this is cause and effect,' he said, 'or whether they're less likely to develop dementia anyway.' So the Stanford team took advantage of a 'natural experiment' when the first shingles vaccine, Zostavax, was introduced in Wales. Health officials set a strict age cutoff: People who turned 80 on or before Sept. 1, 2013, weren't eligible for vaccination, but those even slightly younger were eligible. In the sample of nearly 300,000 adults whose birthdays fell close to either side of that date, almost half of the eligible group received the vaccine, but virtually nobody in the older group did. 'Just as in a randomized trial, these comparison groups should be similar in every way,' Geldsetzer explained. A substantial reduction in dementia diagnoses in the vaccine-eligible group, with a much stronger protective effect in women, therefore constitutes 'more powerful and convincing evidence,' he said. The team also found reduced rates of dementia after shingles vaccines were introduced in Australia and other countries. 'We keep seeing this in one dataset after another,' Geldsetzer said. In the United States, where a more potent vaccine, Shingrix, became available in 2017 and supplanted Zostavax, Oxford investigators found an even stronger effect.
Gulf Today
3 days ago
- Gulf Today
UAE-funded maternity clinics bringing hope to Afghan families
In Jalalabad, Nangarhar province, Afghanistan, Shazia Mohammadi cradles her newborn daughter, Fatima, her seventh child, but the first to be born in a medical clinic. For the first time, Shazia experienced childbirth with access to doctors, medicines, and professional care. Her daughter was also the first baby delivered at one of ten new maternity clinics built by the UAE across Afghanistan, marking the start of a new chapter for maternal health in rural areas. 'Our economic condition was pretty bad all through. Now, thanks to the help we have received, we are much better off. We thank the UAE for this transformation in our lives,' Shazia said. Her husband, Ramadan Mohammadi, recalled their struggles to access care in the past. 'Six of our children were born at home because we couldn't afford transportation to distant hospitals. This is the first time a clinic has been built near our house, and it has been a blessing for us.' These UAE-funded clinics have brought much needed medical care to communities that have long lacked access to even the most basic health services. Located in seven provinces – Nangarhar, Balkh, Herat, Paktia, Paktika, Helmand, and Kandahar – the facilities offer maternity and paediatric care, counselling, contraceptive services, emergency care, medicines and referrals for high-risk cases. They also serve as hubs for community outreach, offering health education, awareness programmes, and life-saving vaccinations, including for COVID-19 and BCG to protect against tuberculosis, to more than 20 people each day. Dr. Ikramullah, a doctor at one of the clinics described the change underway, 'Previously, childbirth happened at home, without any medical support, in unsafe, unhygienic conditions. It is changing now, and the people here are so delighted. We not only ensure safe deliveries, but also provide vaccinations, nutritional assistance, and continuous medical care for mothers and newborns.' He pointed to a young child named Ayesha Qamari as an example of the progress being made, 'The impact of these maternity centres is already being felt. This baby is just one of hundreds of children receiving crucial health checks and vaccinations. This will help bring down the high infant mortality rate in Afghanistan, one of the highest in the world.' According to UNICEF, more than 57 children out of 1,000 in Afghanistan die before reaching the age of five. Ayesha's mother shared her experience, 'We have come to the clinic three or four times. Earlier, we could not afford the cost of transport to the city hospital. Many times, the sick children would not survive the long journey. We are deeply indebted to the UAE for building this clinic in our vicinity.' Beyond healthcare, the initiative is also revitalising the local economy. Small businesses – offering services such as transportation and food supply – have emerged around the clinics and over 100 Afghans have been employed in a range of roles, from medical support to administration. Mawlawi Ameenullah Sharif, Health Director of Nagarhar Province, noted the broader impact, 'We thank the UAE for their investment in Afghanistan's healthcare. This clinic was urgently needed, and now, the poor have access to essential services, including vaccinations, maternal care, and nutrition support.' The clinics are all state-of-the-art, equipped with advanced medical equipment, solar power, mobile units, and ambulances – and staffed by dedicated healthcare professionals. They reflect the UAE's commitment to improving quality of life, empowering women and children, and strengthening local communities in Afghanistan. Expected to impact the lives of more than 100,000 women in the coming years, these facilities represent a transformative step toward accessible healthcare in some of the country's most underserved areas.
